USP18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 7.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
1.879820E-01
Normal-vs-Stage2
7.408200E-01
Normal-vs-Stage3
8.115000E-01
Normal-vs-Stage4
2.740000E-01
Stage1-vs-Stage2
9.236600E-03
Stage1-vs-Stage3
5.712400E-01
Stage1-vs-Stage4
7.333600E-01
Stage2-vs-Stage3
5.346600E-01
Stage2-vs-Stage4
3.446400E-02
Stage3-vs-Stage4
7.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
7.876600E-01
Normal-vs-AfricanAmerican
9.473800E-01
Normal-vs-Asian
5.721400E-01
Caucasian-vs-AfricanAmerican
7.413800E-01
Caucasian-vs-Asian
3.833400E-01
AfricanAmerican-vs-Asian
3.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
8.002800E-01
Normal-vs-Female
7.458000E-01
Male-vs-Female
8.028200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
9.554800E-01
Normal-vs-Age(41-60Yrs)
7.552800E-01
Normal-vs-Age(61-80Yrs)
7.249200E-01
Normal-vs-Age(81-100Yrs)
4.469000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.363600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.787200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.211400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.681000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.480300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.754340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
6.708800E-01
Normal-vs-Daily Drinker
8.805400E-01
Normal-vs-Weekly Drinker
6.905800E-01
Normal-vs-Occasional Drinker
6.679600E-01
Normal-vs-Social Drinker
5.657200E-01
Non Drinker-vs-Daily Drinker
2.371000E-01
Non Drinker-vs-Weekly Drinker
1.908160E-01
Non Drinker-vs-Occasional Drinker
1.402580E-01
Non Drinker-vs-Social Drinker
5.097900E-02
Daily Drinker-vs-Weekly Drinker
5.114000E-01
Daily Drinker-vs-Occasional Drinker
4.414800E-01
Daily Drinker-vs-Social Drinker
3.644000E-01
Weekly Drinker-vs-Occasional Drinker
8.830600E-01
Weekly Drinker-vs-Social Drinker
9.107000E-01
Occasional Drinker-vs-Social Drinker
9.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
3.663000E-01
Normal-vs-Grade 2
1.129640E-01
Normal-vs-Grade 3
1.540600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.930650E-01
Grade 1-vs-Grade 3
1.561640E-01
Grade 1-vs-Grade 4
3.663000E-01
Grade 2-vs-Grade 3
5.360400E-01
Grade 2-vs-Grade 4
1.129640E-01
Grade 3-vs-Grade 4
1.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
8.976400E-01
Normal-vs-NonDiabetic
7.652200E-01
Diabetic-vs-NonDiabetic
5.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
8.691600E-01
Normal-vs-NoPancreatitis
7.837800E-01
Pancreatitis-vs-NoPancreatitis
8.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
8.759000E-01
Normal-vs-N1
7.299400E-01
N0-vs-N1
4.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
3.679000E-01
Normal-vs-TP53-NonMutant
6.822000E-01
TP53-Mutant-vs-TP53-NonMutant
6.057700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap